Next, the invasive capacity of HCC was determined in cells with solo miR-934 inhibitor treatment or cotreatment of miR-934 inhibitor and si-UFM1 through Transwell assay and wound-healing assay. The gene discussed is UFM1; the disease is hepatocellular carcinoma.